[1]Greville G, McCann A, Rudd PM, et al. Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics. 2016;11(12):845-857.[2]Lan Y, Hao C, Zeng X, et al. Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers. Am J Cancer Res. 2016;6(11):2390-2415.[3]Josic D, Martinovic T, Pavelic K. Glycosylation and metastases. Electrophoresis. 2019;40(1):140-150.[4]Silva-filho AF, Sena WLB, Lima LRA, et al. Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction. Cell Physiol Biochem. 2017;41(5): 1801-1829.[5]Christiansen MN,Chik J,Lee L,et al.Cell surface protein glycosylation in cancer. Proteomics. 2014;14(4-5):525-646.[6]Blondeel EJM, Aucoin MG. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeuticrecombinant protein glycoform distributions. Biotechnol Adv. 2018;36(5):1505-1523.[7]Tan Z,Wang C,Li X,et al.Bisecting N-Acetylglucosamine Structures Inhibit Hypoxia-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells. Front Physiol. 2018;9:210.[8]Peixoto A, Fernandes E, Gaiteiro C, et al.Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension. Oncotarget. 2016;7(39):63138-63157.[9]Veillon L, Zhou S, Mechref Y. Quantitative Glycomics: A Combined Analytical and Bioinformatics Approach. Methods Enzymol. 2017;585:431-477.[10]Aon JC, Sun J, Leighton JM, et al. Hypoxia-elicited impairment of cell wall integrity, glycosylation precursor synthesis, and growth in scaled-up high-cell density fed-batch cultures of Saccharomyces cerevisiae. Microb Cell Fact. 2016; 15(1):142. [11]Gil-Marqués ML,Pachón-Ibáñez ME,Pachón J,et al.Effect of Hypoxia on the Pathogenesis ofAcinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection. Infect Immun. 2018;86(10). pii: e00543-18.[12]Gardlik R,Hodosy J,Palffy R,et al.Effects of Orally Administered Bacteria Carrying HIF-1α Gene in an Experimental Model of Intestinal Ischemia. Arch Med Res. 2010l;41(5):332-337.[13]Barel M,Charbit A.Role of Glycosylation/Deglycolysation Processes in Francisella tularensis Pathogenesis. Front Cell Infect Microbiol. 2017;7:71.[14]Barel M,Harduin-Lepers A, Portier L, et al. Host glycosylation pathways and the unfolded protein response contribute to the infection by Francisella. Cellular Microbiology. 2016;12(18): 1763-1781.[15]Miller C, Celli J. Avoidance and subversion of eukaryotic homeostatic autophagy mechanisms by bacterial pathogens. Mol Biol. 2016;17(428):3387-3398.[16]Belotserkovsky I,Brunner K, Pinaud L, et al. Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes. mBio. 2018,9(1):e2309.[17]Sanchez C, Shivshankar P, Stol K, et al. The Pneumococcal Serine-Rich Repeat Protein Is an Intra-Species Bacterial Adhesin That Promotes Bacterial Aggregation In Vivo and in Biofilms. PLoS Pathog. 2010;6(8):e1001044.[18]Salah Ud-Din AIM,Roujeinikova A.Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics. Cell Mol Life Sci. 2018;75(7):1163-1178.[19]McDonald ND,DeMeester KE, Lewis A L, et al. Structural and functional characterization of a modified legionaminic acid involved in glycosylation of a bacterial lipopolysaccharide. J Biol Chem. 2018;293(49):19113-19126. [20]Pyburn T, Bensing B, Xiong Y, et al. A Structural Model for Binding of the Serine-Rich Repeat Adhesin GspB to Host Carbohydrate Receptors. PLoS Pathog.2011l;7(7): e1002112.[21]Garfoot AL, Goughenour KD, Wüthrich M, et al. O-Mannosylation of Proteins Enables Histoplasma Yeast Survival at Mammalian Body Temperatures.2018;9(1): e2121.[22]Bloch S, Zwicker S, Bostanci N, et al. Immune response profiling of primary monocytes and oral keratinocytes to differentTannerella forsythia strains and their cell surface mutants.Molecular Oral Microbiology. 2018;33(2):155-167.[23]Luo B,Li J,Yang T, et al. Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m. Biopharm Drug Dispos.2018;39(8): 378-387.[24]Tolnay AE,Baskin CR,Tumpey TM,et al.Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch Virol.2010;155(6):905-914.[25]Bagdonaite I, Wandall HH. Global Aspects of Viral Glycosylation. Glycobiology. 2018;7(28):443-467.[26]Hargett AA, Wei Q, Knoppova B, et al. Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles. J Virol. 2018;93(1). pii: e01177-1118.[27]Ji Y, Han X, Tian W, et al. V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies. Vaccine. 2018;36(50):7700-7707.[28]Roberts JD, Bebenek K, Kunkel TA.The accuracy of reverse transcriptase from HIV-1.Science.1988;242(4882): 1171-1173.[29]Koel BF, Burke DF, Bestebroer TM, et al. Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution. Science. 2013;342(6161): 976-979.[30]Sun S, Wang Q, Zhao F, et al. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS One. 2011; 6(7):e22844.[31]Mohebbi A, Fotouhi F, Jamali A, et al. Molecular Epidemiology of the Hemagglutinin gene of prevalent influenza virus A/H1N1/ pdm09 among patient in Iran. Virus Res. 2019;259:38-45. [32]Huang Z, Yu L, Huang P, et al. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase. PLOS ONE. 2017;12(7): e178231.[33]Zhao D, Liang L, Wang S, et al. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response. J Virol. 2017;91(7). pii: e02215-2216. [34]Han J, Perez J T, Chen C, et al. Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication. Cell Reports. 2018;23(2):596-607.[35]Peacock TP, Harvey WT, Sadeyen J, et al. The molecular basis of antigenic variation among A(H9N2) avian influenza viruses. Emerg Microbes Infect. 2018;7(1):176. [36]Zhao D, Liang L, Wang S, et al. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response. J Virol. 2017;91(7). pii: e02215-16. [37]Chouaib S,Messai Y, Couve S, et al. Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape. Front Immunol. 2012;3:21.[38]Fedechkin SO, George NL, Wolff JT, et al. Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies. Sci Immunol. 2018;3(21). pii: eaar3534. [39]Leemans A, Boeren M, Van der Gucht W, et al. Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization. Viruses. 2018;10(8). pii: E426[40]Wen D,Li S,Dong F,et al.N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses. MBio. 2018;9(1). pii: e00046-18.[41]Tang C,Yu J.Hypoxia-inducible factor-1 as a therapeutic target in cancer. J Gastroenterol Hepatol. 2013;28(3): 401-405.[42]Hanover JA,Chen W,Bond MR.O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle. 2018;50(3):155-173.[43]Vajaria BN, Patel PS. Glycosylation: a hallmark of cancer?. Glycoconj J. 2017;34(2):147-156.[44]Carvalho-cruz P,Alisson-Silva F,Todeschini AR, et al. Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition. Dev Dyn. 2018;247(3):481-491.[45]Niu Y, Xia Y, Wang J, et al. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway. Mol Med Rep.2017;15(4): 2083-2089.[46]Hanover JA, Chen W, Bond MR. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle. J Bioenerg Biomembr. 2018;50(3):155-173.[47]Burchell JM, Beatson R, Graham R, et al. O-linked mucin-type glycosylation in breast cancer. Biochem Soc Trans. 2018;46(4):779-788. [48]Albuquerque APB, Balmaña M, Mereiter S, et al. Hypoxia and serum deprivation induces glycan alterations in triple negative breast cancer cells. Biol Chem. 2018;399(7):661-672.[49]Rêgo MJ, Vieira De Mello GS, Da Silva Santos CA, et al. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ. Med Mol Morphol. 2013;46(2): 92-96.[50]Chugh S,Barkeer S,Rachagani S,et al.Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice. Gastroenterology.2018;155(5): 1608-1624.[51]Coelho R, Marcos-Silva L, Mendes N, et al. Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. Int J Mol Sci. 2018;19(7). pii: E2045..[52]Höti N, Yang S, Hu Y, et al. Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells. Prostate Cancer Prostatic Dis. 2018; 21(1):137-146. [53]Khan MI, Rath S, Adhami VM, et al. Hypoxia Driven Glycation: Mechanisms and Therapeutic Opportunities. 2017;49:75-82.[54]Zhang J,Shao S,Han D, et al. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway. Int J Oncol. 2018;53(2):659-671.[55]Zhang J,Zhang Q,Lou Y,et al.Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Hepatology. 2018; 67(5):1872-1889.[56]Yamada N, Kato-Kogoe N, Yamanegi K, et al.Inhibition of Asparagine-linked Glycosylation Participates in Hypoxia-induced Down-regulation of Cell-surface MICA Expression. Anticancer Res. 2018;38(3):1353-1359.[57]Tan Z,Wang C,Li X,et al.Bisecting N-Acetylglucosamine Structures Inhibit Hypoxia-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells. Front Physiol. 2018;9:210.[58]Jones RB, Dorsett KA, Hjelmeland AB, et al. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling. J Biol Chem. 2018;293(15): 5659-5667.[59]Dos SS, Sheldon H, Pereira JX, et al. Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation. Oncotarget. 2017;8(30): 49484-49501.[60]Ferrer CM, Lynch TP, Sodi VL, et al.O-GlcNAcylation Regulates Cancer Metabolism and Survival Stress Signaling via Regulation of the HIF-1 Pathway. Molecular Cell. 2014; 54(5):820-831.[61]Yoshida Y,Furukawa J,Naito S, et al.Quantitative analysis of total serum glycome in human and mouse. Proteomics. 2016; 16(21):2747-2758. |